Influence of the Arene Ligand and the Leaving Group on the Anticancer Activity of (Thio)maltol Ruthenium(ii)–(η6-Arene) Complexes
- 11 November 2010
- journal article
- research article
- Published by CSIRO Publishing in Australian Journal of Chemistry
- Vol. 63 (11) , 1521-1528
Abstract
Maltol and its metal complexes have shown promising applications in medicinal chemistry. We report here the synthesis and characterization of Ru(η6-arene)(halido) coordination compounds bearing maltol or thiomaltol ligands and studies on their behaviour in aqueous solution, their reactions with the DNA model guanosine 5′-monophosphate (5′-GMP) and their in vitro anticancer activity in human tumour cell lines. The compounds hydrolyze rapidly and quantitatively to the respective aqua species by exchange of the halido ligand. With pKa values of >8, such species would also be present in biological media and they proved reactive to 5′-GMP. The thiomaltol compounds show promising in vitro activity with IC50 values (50% inhibitory concentration) in the low micromolar range, whereas activity of the maltol complexes is marginal. Variation of the arene ligand (benzene, toluene, p-cymene or biphenyl) resulted only in minor changes in activity.Keywords
This publication has 23 references indexed in Scilit:
- Biospeciation of various antidiabetic VIVO compounds in serumDalton Transactions, 2009
- Transferring the Concept of Multinuclearity to Ruthenium Complexes for Improvement of Anticancer ActivityJournal of Medicinal Chemistry, 2009
- Thioamide Hydroxypyrothiones Supersede Amide Hydroxypyrothiones in Potency against Anthrax Lethal FactorJournal of Medicinal Chemistry, 2009
- High‐Relaxivity MRI Contrast Agents: Where Coordination Chemistry Meets Medical ImagingAngewandte Chemie International Edition, 2008
- Metal-Ligand Exchange Kinetics in Platinum and Ruthenium ComplexesPlatinum Metals Review, 2008
- Classical and Non‐Classical Ruthenium‐Based Anticancer Drugs: Towards Targeted ChemotherapyEuropean Journal of Inorganic Chemistry, 2006
- Synthesis and Antiviral Evaluation of Cyclic and Acyclic 2-Methyl-3-hydroxy-4-pyridinone Nucleoside DerivativesJournal of Medicinal Chemistry, 2005
- Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical ApproachesCurrent Medicinal Chemistry, 2005
- In Vitro and in Vivo Evaluation of Ruthenium(II)−Arene PTA ComplexesJournal of Medicinal Chemistry, 2005
- Highly Selective Binding of Organometallic Ruthenium Ethylenediamine Complexes to Nucleic Acids: Novel Recognition MechanismsJournal of the American Chemical Society, 2002